0000899243-23-000999.txt : 20230105
0000899243-23-000999.hdr.sgml : 20230105
20230105163058
ACCESSION NUMBER: 0000899243-23-000999
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230103
FILED AS OF DATE: 20230105
DATE AS OF CHANGE: 20230105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAINOVIC SACHA
CENTRAL INDEX KEY: 0001053891
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39112
FILM NUMBER: 23511775
MAIL ADDRESS:
STREET 1: 126 EAST 56TH STREET
STREET 2: 20TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: InvOpps IV US, L.P.
CENTRAL INDEX KEY: 0001745076
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39112
FILM NUMBER: 23511776
BUSINESS ADDRESS:
STREET 1: 126 EAST 56TH STREET, 20TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-616-2555
MAIL ADDRESS:
STREET 1: 126 EAST 56TH STREET, 20TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: InvOpps IV, L.P.
CENTRAL INDEX KEY: 0001792575
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39112
FILM NUMBER: 23511777
BUSINESS ADDRESS:
STREET 1: 126 EAST 56TH STREET, 20THFLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-616-2555
MAIL ADDRESS:
STREET 1: 126 EAST 56TH STREET, 20THFLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: InvOpps GP IV, L.L.C.
CENTRAL INDEX KEY: 0001792570
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39112
FILM NUMBER: 23511778
BUSINESS ADDRESS:
STREET 1: 126 EAST 56TH STREET, 20THFLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-616-2555
MAIL ADDRESS:
STREET 1: 126 EAST 56TH STREET, 20THFLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oyster Point Pharma, Inc.
CENTRAL INDEX KEY: 0001720725
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 811030955
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 202 CARNEGIE CENTER
STREET 2: SUITE 106
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: (609) 382-9032
MAIL ADDRESS:
STREET 1: 202 CARNEGIE CENTER
STREET 2: SUITE 106
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-03
1
0001720725
Oyster Point Pharma, Inc.
OYST
0001792570
InvOpps GP IV, L.L.C.
126 EAST 56TH STREET, 20TH FLOOR
NEW YORK
NY
10022
1
0
1
0
0001792575
InvOpps IV, L.P.
126 EAST 56TH STREET, 20TH FLOOR
NEW YORK
NY
10022
1
0
1
0
0001745076
InvOpps IV US, L.P.
126 EAST 56TH STREET, 20TH FLOOR
NEW YORK
NY
10022
1
0
1
0
0001053891
LAINOVIC SACHA
126 EAST 56TH STREET, 20TH FLOOR
NEW YORK
NY
10022
1
0
1
0
Common Stock, par value $0.001 per share
2023-01-03
4
U
0
917768
D
0
I
See Footnotes
Common Stock, par value $0.001 per share
2023-01-03
4
U
0
1850818
D
0
I
See Footnotes
Pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement") by and among Viatris Inc. ("Viatris") and Viatris's wholly owned subsidiary, Iris Purchaser Inc. dated as of November 7, 2022, these shares of common stock, par value $0.001 per share were tendered prior to the Offer Expiration Time (as defined in the Merger Agreement) and disposed of at the Effective Time (as defined in the Merger Agreement) in exchange for the right to receive (a) a cash payment of $11.00 per share (the "Cash Amount") and (b) one non-transferable contractual contingent value right representing the right to receive any applicable milestone payment if specified milestones are achieved pursuant to a Contingent Value Rights Agreement, dated January 3, 2023, by and between Viatris and American Stock Transfer & Trust Company, LLC as Rights Agent.
Reflects securities directly held by InvOpps IV US, L.P. ("Invus IV US").
Reflects securities directly held by InvOpps IV, L.P. ("Invus IV").
InvOpps GP IV, L.L.C. ("InvOpps GP") is the sole general partner of each of Invus IV and Invus IV US. Sacha Lainovic is the managing member of InvOpps GP.
Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
INVOPPS IV US, L.P., By: InvOpps GP IV, L.L.C., its general partner, By: /s/ Sacha Lainovic, Name: Sacha Lainovic, Title: Managing Member
2023-01-05
INVOPPS IV, L.P., By: InvOpps GP IV, L.L.C., its general partner, By: Sacha Lainovic, Name: Sacha Lainovic, Title: Managing Member
2023-01-05
INVOPPS GP IV, L.L.C., By: /s/ Sacha Lainovic, Name: Sacha Lainovic, Title: Managing Member
2023-01-05
/s/ Sacha Lainovic
2023-01-05